Concepedia

B. Martell

BM

4

Publications

413

Citations

4

H-Index

1992

Active since

Affiliations

Pfizer (United States)(Current)

Memorial Sloan Kettering Cancer Center

B. Martell is an author at Pfizer (United States) specializing in medicine, pharmacology, and cancer therapeutics.

Top concepts

MedicinePharmacologyUrologyOncologyCancer TherapyCancer ResearchClinical TrialsPharmacotherapyImmunologyImmunotherapy

Publications per year

1992–2014

4

Publications

4

Immunoconjugates containing novel maytansinoids: promising anticancer drugs.

R. V. J. CHARI, B. Martell, Janet L. Gross et al. · PubMed · 1992 · 266 citations

Medicinal Chemistry, Active Drug, Polymer-drug Conjugate +12

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

Thomas E. Hutson, Ronald M. Bukowski, Brian I. Rini et al. · British Journal of Cancer · 2014 · 85 citations · Full text

Randomized phase II multicenter study of the efficacy and safety of sunitinib on the 4/2 versus continuous dosing schedule as first-line therapy of metastatic renal cell carcinoma: Renal EFFECT Trial.

Robert J. Motzer, Thomas E. Hutson, Mark R. Olsen et al. · Journal of Clinical Oncology · 2011 · 44 citations

First-line Therapy, Urology, Oncology +13

A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).

Thomas E. Hutson, Ronald M. Bukowski, Brian I. Rini et al. · Journal of Clinical Oncology · 2011 · 18 citations

Elderly Patients, Cancer Management, Pharmacotherapy +17

Rows per page

1–4 of 4